Issar Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1995.
1995 Hyderabad, Telangana, India Converted to LLP
Last Updated:
Access Report
About Issar Pharmaceuticals Private Limited

Issar Pharmaceuticals Private Limited, a converted to llp private limited company, was established on 31 October 1995 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG1995PTC022131. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹55.00 Cr and a paid-up capital of ₹55.00 Cr.

It upholds a compliant status. Its leadership includes Rama Krishna Reddy Isanaka (Director), Isanaka Shaalini (Director). Past directors included Sheila Isanaka, Vijay Krishna Akepati, Tatavarthy Satyanarayana Murthy. It holds no open charges and ₹28.25 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at H. No. 8-2-334, Serene Chambers, Flat No. W - 301 & 302, Road No.5, Banja, Ra Hills, Hyderabad, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG1995PTC022131

  • Registration Number

    022131

  • Incorporation Date

    31 October 1995

  • Authorized Capital

    ₹55.00 Cr

  • Paid-Up Capital

    ₹55.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Converted to LLP

Key Metrics
  • Authorised Capital ₹ 55.00 Cr
  • Paid Up Capital ₹ 55.00 Cr
  • Company Age 30 Year, 4 Months
  • Last Filing with ROC 31 Mar 2022
  • Satisfied Charges ₹ 28.25 Cr
  • Revenue Growth **** -98.03%
  • Profit Growth **** -105.85%
  • Ebitda **** -136.00%
  • Net Worth -0.71%
  • Total Assets -4.83%
Company report

Issar Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Issar Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Issar Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rama Krishna Reddy Isanaka Director 02 Sep 1999 Current
Isanaka Shaalini Director 12 Apr 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Oct 2022 Past
Pramod Abcsdd Director 01 Nov 2011 Past
Pramod Abcsdd Additional Director 25 Jul 2022 Past
Pramod Abcsdd Director 26 Nov 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Issar Pharmaceuticals.

Issar Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.03% decrease. The company also saw a substantial fall in profitability, with a 105.85% decrease in profit. The company's net worth dipped by a decrease of 0.71%.

Issar Pharmaceuticals revenue growth over time
Issar Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -98.03%
*******
*******
*******
*******
Revenue from Operations
*******
 -100.00%
*******
*******
*******
*******
Total Assets
*******
 -4.83%
*******
*******
*******
*******
Profit or Loss
*******
 -105.85%
*******
*******
*******
*******
Net Worth
*******
 -0.71%
*******
*******
*******
*******
EBITDA
*******
 -136.00%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Issar Pharmaceuticals?

In 2022, Issar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹282,530,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 24.20 Cr
  • Technology Development Board : 2.75 Cr
  • Uti Bank Limited : 1.00 Cr
  • The Karnataka Bank Limited : 0.25 Cr
  • Karnataka Bank : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
16 Jun 2011 State Bank Of India ₹24.20 Cr Satisfied
05 Jun 2006 Uti Bank Limited ₹1.00 Cr Satisfied
12 Nov 2005 The Karnataka Bank Limited ₹2.50 M Satisfied
12 Nov 2005 The Karnataka Bank Limited ₹0.00 Satisfied
19 Nov 2003 Karnataka Bank ₹0.53 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Issar Pharmaceuticals?

Unlock and access historical data on people associated with Issar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Issar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Issar Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Issar Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Issar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.

  • Balance Sheet

    Issar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    A charge registered on 16 Jun 2011 via Charge ID 10294014 with State Bank Of India was fully satisfied on 17 Jun 2016. was recorded as a recent event.

  • Director Appointment

    Isanaka Shaalini was appointed as a Director was appointed as a Director on 12 Apr 2016 & has been associated with this company since 9 years 11 months . was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of India amounted to Rs. 24.20 Cr with Charge ID 10294014 was registered on 16 Jun 2011. was completed.

  • Charges

    Progress on A charge registered on 05 Jun 2006 via Charge ID 10006700 with Uti Bank Limited was fully satisfied on 07 Jun 2011. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Issar Pharmaceuticals Private Limited?

The CIN of Issar Pharmaceuticals Private Limited is U24239TG1995PTC022131.

Where is Issar Pharmaceuticals Private Limited headquartered?

Issar Pharmaceuticals Private Limited is headquartered at H. No. 8-2-334, Serene Chambers, Flat No. W - 301 & 302, Road No.5, Banja, Ra Hills, Hyderabad, Telangana, 500034.

When was Issar Pharmaceuticals Private Limited incorporated?

Issar Pharmaceuticals Private Limited was incorporated on 31 October 1995.

Who are the current directors of Issar Pharmaceuticals Private Limited?

The current directors of Issar Pharmaceuticals Private Limited are

What is the primary industry of Issar Pharmaceuticals Private Limited?

The primary industry of Issar Pharmaceuticals Private Limited is Manufacturing.

Is Issar Pharmaceuticals Private Limited a listed company?

Issar Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Issar Pharmaceuticals Private Limited?

The authorized capital of Issar Pharmaceuticals Private Limited is ₹55.00 Cr, and the paid-up capital is ₹55.00 Cr.

What is the compliance status of Issar Pharmaceuticals Private Limited?

The compliance status of Issar Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available